FDA Clearance Tracker · P230020-S003
Altius Direct Electrical Nerve Stimulation System
Last checked: Nov 20, 2026Latest source record: Jun 25, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 25, 2025
Approved
Time to decision
85 days
Received Apr 1, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P230020-S003
- Device name
- Altius Direct Electrical Nerve Stimulation System
- Applicant
- Neuros Medical, Inc.
- Applicant location
- Aliso Viejo, CA
- Received
- Apr 1, 2025
- Decided
- Jun 25, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P230020
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
approval for a second battery charge current option of 100 mA, in addition to the battery charge current of 50 mA previously approved under the original PMA P230020.
Source documents
Other decisions for Neuros Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Altius® Direct Electrical Nerve Stimulation SystemBreakthroughPMA
P230020 · Decided Aug 26, 2024 · 423 days after receipt
Device type: stimulator, nerve terminus, totally implanted for chronic intractable post-amputation pain of the lower limb (SAZ) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.